Live Breaking News & Updates on Hfpef

Stay updated with breaking news from Hfpef. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Semaglutide improves symptoms and function in obesity-related heart failure

1. Semaglutide showed significant improvements in KCCQ-CSS score and reduction in body weight compared to placebo. 2. There were fewer serious adverse events in the semaglutide group. Evidence Rating Level: 1 (Excellent) Study Rundown: Obesity and diabetes lead to poor prognosis in patients with heart failure. GLP-1 receptor agonists, such as semaglutide, have been shown

Rating-level , Obesity-related-heart-failure , Between-mar , Glp-1-agonist , Glp-1-receptor-agonist , Glucagon-like-peptide-1-glp-receptor-agonists , Heart-failure , Hfpef , Hfpef-heart-failure-with-preserved-ejection-fraction , Obesity , Semaglutide

Semaglutide improves obesity-related heart failure symptoms

1. In this randomized controlled trial, semaglutide was more effective in reducing heart failure-related symptoms and physical limitations in patients with obesity-related heart failure and type 2 diabetes mellitus (T2DM) than placebo. 2. Patients with obesity-related heart failure and T2DM exhibited greater weight loss with semaglutide than placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Heart

United-states , Minute-medicine-inc , Rating-level , Semaglutide-treatment-effect , Heart-failure , Preserved-ejection-fraction , Diabetes-mellitus , Kansas-city-cardiomyopathy-questionnaire , Confidence-interval , Cardiology , Chronic-disease

There Is No Interaction Between BMI and SGLT2 Inhibitor Efficacy in HF, Review Finds

Among patients with heart failure (HF), those taking dapaglifozin or empaglifozin had a 30% odds reduction in HF hospitalization, 14% odds reduction in cardiovascular mortality, and a 10% odds reduction in all-cause mortality compared with patients taking placebo.

United-states , American , Wolfram-doehner , Olivier-le-moal , American-journal , Managed-care , Intern-emerg , Eurj-heart , Heart-fail , Heart-failure , Cardiovascular

More Physical Activity Linked to Reduced HF Risk in Older Women

Increased daily step count was linked to reduced risks of overall heart failure (HF) and HF with preserved or reduced ejection fraction.

Cardiovascular-health-in-older-women , Objective-physical-activity , Cardiovascular-health , Older-women , Hispanic-white , Hispanic-black , Heart-failure , Hf , Hfpef , Hfref , Jama-cardiology

Sleep Apnea Prevalence in Cardio-Oncology Patients Similar to Other Risk Factors

Sleep apnea prevalence in cardiology patients was similar to the rates in patients with heart failure., and sleep apnea prevalence in cardio-oncology patients was the same or greater than other traditional risk factors.

Kentucky , United-states , Baptist-health-minik-das , Baptist-health-in-louisville , Baptist-health , Sleep-apnea , Obstructive-sleep-apnea , Cardiovascular-risk , Heart-failure , Risk-factors , Sleep

Deepak Bhatt, MD, MPH: Need for In-Hospital Initiation, Uptitration of GDMT in Acute Heart Failure

Deepak Bhatt, MD, MPH, discusses the need to improve in-hospital initiation and uptitration of guideline-directed medical therapy in heart failure.

Eli-lilly , European-society-of-cardiology , Astrazeneca , Amgen , Pfizer , European-society , Confidence-interval , Eurj-heart , Recent-worsening-heart , Cardiology , Heart-failure , Gdmt-in-heart-failure

TET2 CHIP an Independent Risk Factor for HFpEF, Study Says

Researchers found TET2 clonal hematopoiesis of indeterminate potential (CHIP) to be an independent risk factor associated with incident heart failure with preserved ejection fraction (HFpEF).

United-states , American , Women-health-initiative , Jackson-heart-study , Health-initiative , African-american , Heart-failure , Tet2 , Chip , Hfpef , Hfref

Ferrokinetics Impacts Physical Therapy Responses in HFpEF

Compared to the usual care, patients with HFpEF in the active arms demonstrated less improvement in peakVO2 when they had iron deficiency and lower values of ferritin and transferrin saturation, according to a new study.

Spain , Valencia , Carabobo , Venezuela , Palau , York-heart-association , European-society-of-cardiology , Patricia-palau , Universitat-de-val , European-society , Universitari-de-val

Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin

The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.

United-states , American , American-heart-association-circulation , York-heart-association , Kansas-city-cardiomyopathy-questionnaire , Total-symptom-score , Limitation-scale , American-heart-association , New-york-heart-association , Heart-failure , Hfref